CAMP4 Therapeutics
CAMP · NASDAQ
$3.16+$0.02 (+0.64%)TodayMarket closed ·
Prev close $3.14
EPS: actual vs estimate
Beat the estimate in 2 of the last 8 quarters, by 11.4% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.2157 | -$0.22 | −2.0% |
| Q1 FY26 | -$0.2142 | -$0.32 | −49.4% |
| Q4 FY25 | -$0.3094 | -$0.86 | −178.0% |
| Q3 FY25 | -$0.4879 | -$0.55 | −12.7% |
| Q2 FY25 | -$0.6854 | -$0.62 | +9.5% |
| Q1 FY25 | -$0.714 | -$0.62 | +13.2% |
| Q4 FY24 | -$0.839 | -$2.83 | −237.3% |
| Q3 FY24 | -$1.09 | -$24.19 | −2111.2% |
Earnings calls
- Analyst/Investor Day - Camp4 Therapeutics Corporation
- 44th Annual J.P. Morgan Healthcare Conference
- 24th Annual Needham Virtual Healthcare Conference
- Leerink’s Global Healthcare Conference 2025
- Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025
- CAMP - Earnings call 3 2024
- CAMP - Earnings call 2 2024
- CAMP - Earnings call Q1 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.